Efficacy and safety of PD‐1/PD‐L1 inhibitors in elderly patients with advanced non‐small cell lung cancer
Abstract Objective This study aimed to investigate the efficacy and safety of PD‐1/PD‐L1 inhibitors in treatment of elderly patients with advanced non‐small cell lung cancer (NSCLC). Methods Patients with advanced NSCLC ≥70 years old who received PD‐1/PD‐L1 inhibitors in our hospital were retrospect...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2024-05-01
|
| Серія: | The Clinical Respiratory Journal |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1111/crj.13763 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|